Skip to main content
NVDA-2.35%AAPL+3.52%GOOGL+0.64%MSFT+0.21%AMZN-0.27%TSM-1.54%SPCX+0.33%AVGO-1.07%META-1.41%TSLA-1.25%SKHY-5.19%MU-4.84%BRK-B+0.17%LLY-0.02%JPM-0.32%WMT-0.09%AMD-3.38%V+0.09%XOM+0.71%ASMLa-1.66%JNJ-0.27%INTC-5.62%MA-0.34%0700.HK-1.94%1398.HK+0.79%ORCL-5.29%ABBV+1.56%BAC-0.17%CSCO-1.75%CVX-0.46%COST+0.01%KO+0.37%LRCX-5.75%CAT-1.41%AP2d-1.55%0005.HK-0.78%AMAT-3.31%UNH-1.18%HSBA.L-1.30%DELL-5.08%PG+0.17%MS-1.01%GE-0.46%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.04%HD-1.65%0939.HK+1.66%GS-1.00%NZDJPY-2.62%AUDJPY-1.85%CHFJPY-1.62%NZDCAD-1.44%EURNZD+1.42%NZDUSD-1.41%GBPNZD+1.36%GBPJPY-1.27%EURJPY-1.25%USDJPY-1.23%CADJPY-1.19%NZDCHF-1.04%USDZAR+1.02%USDSEK+0.94%USDNOK+0.90%EURZAR+0.83%AUDNZD+0.79%GBPZAR+0.75%EURSEK+0.74%EURNOK+0.71%USDTHB+0.69%AUDCAD-0.69%AUDDKK-0.64%AUDUSD-0.63%EURAUD+0.61%CHFSEK+0.59%USDMXN+0.58%GBPAUD+0.56%CHFNOK+0.55%AUDSGD-0.54%USDPLN+0.46%GBPTRY+0.41%CADCHF+0.41%NZDSGD-0.41%USDCHF+0.40%NOKJPY-0.39%EURCHF+0.37%GBPCHF+0.33%GBPHKD+0.32%USDSGD+0.29%GBPMXN-0.28%EURPLN+0.27%AUDCHF-0.24%SGDJPY+0.22%EURHKD-0.20%USDDKK+0.19%USDILS+0.16%NZDMXN-0.13%USDTRY+0.11%USDCNH+0.10%EURSGD+0.10%GBPCAD-0.09%EURCNH-0.07%AUDNOK+0.07%CHFSGD-0.06%EURCZK-0.06%EURCAD-0.05%PLNJPY+0.05%GBPUSD-0.04%EURGBP+0.04%USDCOP-0.04%EURUSD-0.03%USDCAD-0.02%USDHKD+0.02%GBPSGD+0.01%EURDKK0.00%XPTUSD-6.23%UKOIL+5.73%USOIL+5.51%GAGUSD-5.34%XAGUSD-5.34%HG1-4.79%XAUUSD-1.76%GAUUSD-1.76%XNGUSD+1.47%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.47%ETHUSD-0.22%USDTUSD-0.04%XRPUSD-3.09%SOLUSD-1.79%TRXUSDT+0.18%ZECUSDT-9.75%DOGEUSD-2.58%XMRUSDT+0.27%LINKUSD-1.60%XLMUSD-1.81%BCHUSDT-9.99%LTCUSD-1.84%UNIUSD-1.24%TONUSD+24.88%HBARUSDT-2.27%SUIUSD-4.27%TAOUSDT-5.90%AAVEUSD-2.16%DOTUSDT-1.92%ICPUSDT-0.83%ONDOUSDT-3.59%WLDUSDT-3.39%ATOMUSDT-3.46%ARBUSDT-1.21%JUPUSDT-4.25%INJUSDT-3.06%STXUSDT-4.53%FETUSDT-3.21%TIAUSDT-1.52%PYTHUSDT-1.74%SEIUSDT-6.02%IMXUSDT-3.85%WIFUSDT-5.38%GRTUSDT-3.98%OPUSDT-4.00%POLUSDT-4.64%IOTAUSDT-4.29%AXSUSDT-2.47%FARTCOINUSDT-3.51%EOSUSDT-2.91%DYDXUSDT-2.34%ORDIUSDT-1.27%GALAUSDT-3.65%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.35%AAPL+3.52%GOOGL+0.64%MSFT+0.21%AMZN-0.27%TSM-1.54%SPCX+0.33%AVGO-1.07%META-1.41%TSLA-1.25%SKHY-5.19%MU-4.84%BRK-B+0.17%LLY-0.02%JPM-0.32%WMT-0.09%AMD-3.38%V+0.09%XOM+0.71%ASMLa-1.66%JNJ-0.27%INTC-5.62%MA-0.34%0700.HK-1.94%1398.HK+0.79%ORCL-5.29%ABBV+1.56%BAC-0.17%CSCO-1.75%CVX-0.46%COST+0.01%KO+0.37%LRCX-5.75%CAT-1.41%AP2d-1.55%0005.HK-0.78%AMAT-3.31%UNH-1.18%HSBA.L-1.30%DELL-5.08%PG+0.17%MS-1.01%GE-0.46%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.04%HD-1.65%0939.HK+1.66%GS-1.00%NZDJPY-2.62%AUDJPY-1.85%CHFJPY-1.62%NZDCAD-1.44%EURNZD+1.42%NZDUSD-1.41%GBPNZD+1.36%GBPJPY-1.27%EURJPY-1.25%USDJPY-1.23%CADJPY-1.19%NZDCHF-1.04%USDZAR+1.02%USDSEK+0.94%USDNOK+0.90%EURZAR+0.83%AUDNZD+0.79%GBPZAR+0.75%EURSEK+0.74%EURNOK+0.71%USDTHB+0.69%AUDCAD-0.69%AUDDKK-0.64%AUDUSD-0.63%EURAUD+0.61%CHFSEK+0.59%USDMXN+0.58%GBPAUD+0.56%CHFNOK+0.55%AUDSGD-0.54%USDPLN+0.46%GBPTRY+0.41%CADCHF+0.41%NZDSGD-0.41%USDCHF+0.40%NOKJPY-0.39%EURCHF+0.37%GBPCHF+0.33%GBPHKD+0.32%USDSGD+0.29%GBPMXN-0.28%EURPLN+0.27%AUDCHF-0.24%SGDJPY+0.22%EURHKD-0.20%USDDKK+0.19%USDILS+0.16%NZDMXN-0.13%USDTRY+0.11%USDCNH+0.10%EURSGD+0.10%GBPCAD-0.09%EURCNH-0.07%AUDNOK+0.07%CHFSGD-0.06%EURCZK-0.06%EURCAD-0.05%PLNJPY+0.05%GBPUSD-0.04%EURGBP+0.04%USDCOP-0.04%EURUSD-0.03%USDCAD-0.02%USDHKD+0.02%GBPSGD+0.01%EURDKK0.00%XPTUSD-6.23%UKOIL+5.73%USOIL+5.51%GAGUSD-5.34%XAGUSD-5.34%HG1-4.79%XAUUSD-1.76%GAUUSD-1.76%XNGUSD+1.47%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.47%ETHUSD-0.22%USDTUSD-0.04%XRPUSD-3.09%SOLUSD-1.79%TRXUSDT+0.18%ZECUSDT-9.75%DOGEUSD-2.58%XMRUSDT+0.27%LINKUSD-1.60%XLMUSD-1.81%BCHUSDT-9.99%LTCUSD-1.84%UNIUSD-1.24%TONUSD+24.88%HBARUSDT-2.27%SUIUSD-4.27%TAOUSDT-5.90%AAVEUSD-2.16%DOTUSDT-1.92%ICPUSDT-0.83%ONDOUSDT-3.59%WLDUSDT-3.39%ATOMUSDT-3.46%ARBUSDT-1.21%JUPUSDT-4.25%INJUSDT-3.06%STXUSDT-4.53%FETUSDT-3.21%TIAUSDT-1.52%PYTHUSDT-1.74%SEIUSDT-6.02%IMXUSDT-3.85%WIFUSDT-5.38%GRTUSDT-3.98%OPUSDT-4.00%POLUSDT-4.64%IOTAUSDT-4.29%AXSUSDT-2.47%FARTCOINUSDT-3.51%EOSUSDT-2.91%DYDXUSDT-2.34%ORDIUSDT-1.27%GALAUSDT-3.65%NOTUSDT-2.97%RONINUSDT-2.64%
BB

Beta Bionics, Inc. (BBNX)

NASDAQ • Healthcare

$17.42
-$1.9 (-9.9%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$19.14
Previous Close$17.42
Day Range$17.26 - $19.54
Avg. Volume (3M)1M
Market Cap$759.5M
52 Week Range
$8.8$32.71
Next EarningsIn 47 daysOct 27, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$32M100%
Gross Profitminus cost of goods$18.9M59%

In plain terms: out of every $100 in revenue, Beta Bionics, Inc. currently loses $73.

Fundamentals & Financials

Revenue (TTM)
$119M
Net Income (TTM)
-$72.9M
EPS (TTM)
-$1.68
ROA (TTM)
-24.96%
Current Ratio
8.88

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+28.6%Q1 2026-$0.3
+7.5%Q2 2026-$0.49
+8.8%Q3 2026-$0.53
Next

Oct 27

in 47 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +8.8%

Beta Bionics beat expectations on both the top and bottom line in the second fiscal quarter of 2026, reported July 29, 2026, as revenue rose 37.8% to about $32.0 million, driven by its insulin-delivery systems lineup led by the iLet Bionic Pancreas platform. Revenue of $32.0 million topped the $31.5 million estimate, +2%, while EPS of -$0.53 topped the -$0.58 estimate by $0.05 (down from -$0.39 a year ago). Profitability tracked higher gross margin but remained loss-making at the operating line, with gross profit of roughly $18.9 million and gross margin at 59.0% alongside an operating loss of about $25.6 million and operating margin of -79.9%. Net income was -$23.4 million (down from -$16.9 million a year ago, -38.7%), and operating cash flow was negative at roughly $14.6 million. For the next period, consensus calls for EPS of -$0.55 on revenue of $35.0 million.

View full earnings history

About Beta Bionics, Inc.

Beta Bionics, Inc. develops insulin-delivery systems for people with diabetes who depend on insulin and trades on the NASDAQ under BBNX as a medical-device company in healthcare. Its products center on automated dosing platforms, and the company generated $100.3 million of revenue in FY2025.

Name
Beta Bionics, Inc.
CEO
Sean T. Saint
Website
www.betabionics.com
Industry
Healthcare
Year Founded
2015
Employees
422

Today's Snapshot

AI-generated

So far today, BBNX is trading 4.1% lower at 16.71, in line with a weaker sector. Beta Bionics faces a class-action lawsuit alleging investors were harmed.

Trading Volume

Below 10d avg (837.4K)

695.9K

vs S&P 500 Today

Strong Underperformance

-3.46%

Updated: September 10, 2026 at 19:38 UTC

Technical Indicators

2 Buy2 Neutral4 Sell
BBNX is under clear downward pressure with a resolute trend indicated by ADX near 30 and pronounced negative momentum, while the price sits well beneath most short- and medium-term moving averages. Volume trends are confirmatory—on-balance volume is deeply negative—while ATR is elevated, signaling outsized intraday swings that accentuate downside risk. MACD and CCI offer little support, and classic pivots lie above the market, adding resistance. Technical takeaway: Sell — dominant downtrend supported by negative momentum, weak volume profile, and higher volatility.
All signals
  • EMA (5 indicators)$16.22 - $18.58
    Sell
  • RSI (14)40.44
    Neutral
  • Stochastic %K (14, 3, 3)15.71
    Buy
  • MACD Level (12, 26)0.41
    Neutral

Peers & Related Assets

PLSEPulse Biosciences, Inc.
$52.97+8.6%
PGENPrecigen, Inc.
$6.8-1.0%
KMTSKestra Medical Technologies, Ltd.
$24.07-6.1%
ORICORIC Pharmaceuticals, Inc.
$12.5-0.9%
STAASTAAR Surgical Company
$23.62-2.2%
AHCOAdaptHealth Corp.
$5.7-7.9%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.